The attorneys on Much's Life Sciences team have been involved in the biotech business since its inception. In the 1980s, when technological advancements were changing the medical and pharmaceutical landscapes at a lightning pace, we worked side-by-side with companies at the forefront of innovation. And then in the 1990s, when venture capital-backed life sciences companies were being acquired by public companies or going public themselves, our attorneys supported them in securing financing and navigating the exit process.
Decades later, clients continue to rely on the legal and scientific backgrounds and experience of our attorneys. Businesses of every size, as well as academic and research institutions, call on Much's lawyers to protect and strategically manage their most valuable assets.
Our experience is extensive and diverse. Much's attorneys have been involved in the procurement and enforcement of intellectual property protection for drugs, medical devices, biosimilars and biologics worth tens of billions of dollars in the aggregate in today's market. We have counseled companies that developed technologies that earned two Nobel Prizes. Our clients range from innovative life sciences startups to some of the biggest biologics and medical device companies in the world, many of which have tens of thousands of employees and tens of billions of dollars in annual revenue.
Much's life sciences services include counsel in the areas of:
- Venture capital, seed-stage, private equity and debt financings and IPOs for both companies and investors, including the special concerns of public company investors in privately held startups
- Domestic and international mergers and acquisitions and investments
- Patent portfolio planning, procurement and enforcement
- Licensing agreements
- Post-grant proceedings, including reexaminations, oppositions and inter partes reviews
- Litigation related to trade secret violations as well as patent enforcement, inventorship, validity and licensing disputes
- Labor and employment matters, including dispute resolution
- Real estate purchases and sales, including lab expansions